Pre-filled syringes in developed and developing region: An insight into Regulatory considerations
A Pre-filled syringe is a disposable syringe that is supplied already loaded with the substance to be injected. It is a unit dose of parenteral medication to which a needle has been fixed by a producer. They are small which make them easy to carry and are dependable for delivering a precise dose of medication. These reasons are leading to growth of parenteral medication in pharmaceutical market. The intent of this review article is to provide information on regulatory guidelines involved in submission approach for marketing authorization of pre-filled syringe in developed region (USA, EU) and developing region (India). It also further explains about complexities associated with Pre-filled syringes in terms of regulations, submission approaches and quality development considerations in developing region. There is a need to develop an effective regulatory framework to make regulations of Pre-filled syringes more comprehensive for regulatory bodies. A harmonized forum to be made through which single application can be made and single review process can be followed to avoid deviations in regulatory pathways.
2. Kim S. FDA on Pre-filled syringes and Combination Products [Internet]. QbD works; 2015 [cited 2018 Nov 21]. Available from: http://qbdworks.com/fda-on-pre-filled -syringes-and-combination-products/
3. FDA Organization - Office of Combination Products [Internet]. USA: Office of the Commissioner; 2018 [cited 2018 Dec 23]. Available from:
4. Kim S. How to apply QbD to Drug Device Combination Products [Internet]. QbD works [cited 2018 Dec 25]. Available from:
5. USA. Food and Drug Administration. Guidance for Industry and FDA Staff: Current Good Manufacturing Practice Requirements for Combination Products. Silver spring: U.S. Department of Health and Human Services; 2017
6. Kotha V, Elphine P, Rao NR, Bhrama SD. Regulatory strategy for registration of combination products to USFDA. Int J Drug Regul Aff [Internet]. 2018 Feb 13[cited 2019 Apr 23]; 2(3):27-42. Available from:
7. Sardeson S. Combination Products Regulation in the United States [Internet]. ITA-FDA Medical Devices Regulatory Capacity Building Training Program for International Medical Devices Regulators. California: 3M Healthcare; 2014:1-31.
8. B SB, Patel PM, Patel NM. Regulatory Requirements of Combinational Products: An Overview (USFDA). Int J Pharm & Bio Sci. 2011; 2(3):822-7.
9. USA. Food and Drug Administration. eCTD technical conformance guide: Guidance for Industry Providing Regulatory Submissions in Electronic Format-Certain Human Pharmaceutical Product Applications and Related Submissions Using the eCTD Specifications. U.S. Department of Health and Human Services; 2018.
10. USA. Food and Drug Administration. The Comprehensive Table of Contents Headings and Hierarchy [Internet]. 2004 [cited 2019 Jan 11]. Available from:
11. Europe. Official Journal of European Union. Regulation (EU) 2017/ 745 of the European parliament and the Council of European Union; 2017.
12. Hoxey E. Changes in the Medical Devices Regulation affect drug delivery devices [Internet]. UK: British Standards Association; 2019 [cited 2019 Jan 23]. Available from:
13. Roan S. Submission Strategies and Post Approval Changes for Drug-PMOA Combination Products [Internet]. United States: Xavier Health; 2018 [cited 2019 Jan 23]. Available from:
14. An Industry Perspective on Article 117 of the EU Medical Devices Regulation and the Impact on how Medicines are assessed. EBE-EFPIA Reflection Paper [Internet]. 2018 July 23 [cited 2019 Jan 13]. Available from:
15. Kapoor V, Kaushik D. A comparative study of regulatory prospects for drug-device combination products in major pharmaceutical jurisdictions. J Generic Med Bus J Generic Med Sect. 2013; 10(2):86-96.
16. CDSCO 2015 database [Internet]. CDSCO; 2015 [cited 2019 Feb 23]. Available from:
17. 2018 database [Internet]. CDSCO; 2018 [cited 2019 Feb 26]. Available from:
18. CDSCO. 2015 database [Internet]. CDSCO; 2019 [cited 2019 Feb 20]. Available from:
19. IPC. Indian Pharmacopoeia Commission. A guidance document for medical devices. National Coordination Centre-Materiovigilance Programme of India: Ministry of Health & Family Welfare Government of India; 2018.
20. CDSCO India. Registration Certificate issued for import of devices into India under Drugs and Cosmetics Rules, 1945. Ministry of Health & Family Welfare Government of India; 2012.
21. Kumar D, Yadav V, Mathewson N. A new regulatory paradigm for medical devices in India. Regulatory Focus. 2017 Dec.p. 1-15.
22. Senthil V, Priyadarshini R, Ramachandran A. GG and SA. Regulatory process for import and export of drugs in India. International Journal of Pharmaceutical Sciences and Research. 2015 Dec; 6(12):4989-99.
23. CDSCO India. Central drugs standard control organisation Directorate general of health services. Checklist for Form 10 (drugs). Ministry of Health and Family Welfare Government of India; 2010.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The International Journal of Drug Regulatory affairs require a formal written transfer of copyright from the author(s) for each article published. We therefore ask you to complete and return this form, retaining a copy for your records. Your cooperation is essential and appreciated. Any delay will result in a delay in publication.
I/we have read and agree with the terms and conditions stated Page 2 of this agreement and I/we hereby confirm the transfer of all copyrights in and relating to the above-named manuscript, in all forms and media, now or hereafter known, to the International Journal of Drug Regulatory affairs, effective from the date stated below. I/we acknowledge that the IJDRA is relying on this agreement in publishing the above-named manuscript. However, this agreement will be null and void if the manuscript is not published in the IJDRA.
Download link for COPYRIGHT FORM